Last updated: 18 July 2019 at 5:14pm EST

Venture Partners V, L.P.Pol... Net Worth




The estimated Net Worth of Venture Partners V, L.P.Pol... is at least $9.71 Million dollars as of 5 August 2015. Venture Pol owns over 10,744 units of T2 Biosystems Inc stock worth over $4,671,109 and over the last 10 years Venture sold TTOO stock worth over $5,038,766.

Venture Pol TTOO stock SEC Form 4 insiders trading

Venture has made over 9 trades of the T2 Biosystems Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently Venture sold 10,744 units of TTOO stock worth $161,375 on 5 August 2015.

The largest trade Venture's ever made was selling 44,997 units of T2 Biosystems Inc stock on 20 July 2015 worth over $700,603. On average, Venture trades about 31,112 units every 4 days since 2014. As of 5 August 2015 Venture still owns at least 2,030,917 units of T2 Biosystems Inc stock.

You can see the complete history of Venture Pol stock trades at the bottom of the page.



Insiders trading at T2 Biosystems Inc

Over the last 10 years, insiders at T2 Biosystems Inc have traded over $18,971,153 worth of T2 Biosystems Inc stock and bought 5,875,341 units worth $59,722,018 . The most active insiders traders include Adrian M Jones, Group L.P.Crg Partners Iii ..., and Thomas J. Carella. On average, T2 Biosystems Inc executives and independent directors trade stock every 20 days with the average trade being worth of $764,499. The most recent stock trade was executed by John J Iii Sperzel on 24 February 2024, trading 67 units of TTOO stock currently worth $154.



What does T2 Biosystems Inc do?

t2 biosystems is developing innovative diagnostic products to improve patient health. with two fda-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, t2 biosystems is an emerging leader in the field of in vitro diagnostics. our initial development efforts target sepsis, hemostasis, bacteria and lyme disease, which are areas of significant unmet medical need. the company is utilizing its proprietary t2 magnetic resonance platform, or t2mr®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. at t2 biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. we invite you to apply for one of our open positions at www



What does T2 Biosystems Inc's logo look like?

T2 Biosystems Inc logo

Complete history of Venture Pol stock trades at T2 Biosystems Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
5 Aug 2015 Venture Partners V, L.P.Pol...
Sale 10,744 $15.02 $161,375
5 Aug 2015
2,030,917
23 Jul 2015 Venture Partners V, L.P.Pol...
Sale 15,399 $15.04 $231,601
23 Jul 2015
2,041,284
20 Jul 2015 Venture Partners V, L.P.Pol...
Sale 44,997 $15.57 $700,603
20 Jul 2015
2,056,143
15 Jul 2015 Venture Partners V, L.P.Pol...
Sale 44,997 $16.26 $731,651
15 Jul 2015
2,099,565
13 Jul 2015 Venture Partners V, L.P.Pol...
Sale 29,998 $16.57 $497,067
13 Jul 2015
2,142,987
8 Jul 2015 Venture Partners V, L.P.Pol...
Sale 44,997 $16.25 $731,201
8 Jul 2015
2,171,935
2 Jul 2015 Venture Partners V, L.P.Pol...
Sale 44,997 $15.91 $715,902
2 Jul 2015
2,215,357
29 Jun 2015 Venture Partners V, L.P.Pol...
Sale 44,997 $16.09 $724,002
29 Jun 2015
2,258,779
22 Jun 2015 Venture Partners V, L.P.Pol...
Sale 29,998 $18.18 $545,364
22 Jun 2015
2,345,623


T2 Biosystems Inc executives and stock owners

T2 Biosystems Inc executives and other stock owners filed with the SEC include: